ACM
SLDB icon

Aquatic Capital Management’s Solid Biosciences SLDB Stock Holding History

Aquatic Capital Management’s Portfolio SLDB Stock Details SLDB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-3,710
Closed -$20.9K – 1778
2025
Q4 		$20.9K Buy
+3,710
New +$20.1K ﹤0.01% 1313
2024
Q3 		– Sell
-400
Closed -$2.27K – 1504
2024
Q2 		$2.27K Buy
+400
New +$3.58K ﹤0.01% 1157

Other funds holding SLDB

PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.68B AUM 126.09% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return

Aquatic Capital Management's SLDB Position: Q1 2026 in Review

Aquatic Capital Management sold out of Solid Biosciences (SLDB) in Q1 2026, closing a stake of 3,710 shares — an estimated $20.9K sold.

Aquatic Capital Management first reported a position in SLDB in Q2 2024 and held it in 2 quarters. The position peaked at $20.9K in Q4 2025. 150 funds tracked by Wall St. Rank hold SLDB as of Q1 2026.

  • Aquatic Capital Management reported no remaining Solid Biosciences position as of Q1 2026 after selling out during the quarter.
  • Aquatic Capital Management sold 3,710 Solid Biosciences shares in Q1 2026, an estimated $20.9K.
  • Aquatic Capital Management first reported a position in Solid Biosciences in Q2 2024 and held it in 2 quarters.
  • Aquatic Capital Management's Solid Biosciences position peaked at $20.9K in Q4 2025.
  • 150 funds tracked by Wall St. Rank held Solid Biosciences as of Q1 2026.

Based on Aquatic Capital Management's 13F filing for Q1 2026, filed 15 May 2026.